Legend Biotech (LEGN) Free Cash Flow (2019 - 2025)

Legend Biotech has reported Free Cash Flow for 7 years, with the latest figure at -$12.2 million in Q4 2025.

• For the quarter ending Q4 2025, Free Cash Flow rose 88.7% year-over-year to -$12.2 million; the trailing twelve-month figure through Dec 2025 stood at -$84.0 million (up 46.91% YoY), and the FY2025 full-year result was -$100.2 million, up 36.62% from the prior year.
• Free Cash Flow for Q4 2025 stood at -$12.2 million, down from $33.8 million in the prior quarter.
• The five-year high for Free Cash Flow was $33.8 million in Q3 2025, with the low at -$156.3 million in Q4 2021.
• Historically, Free Cash Flow has averaged -$53.3 million across 5 years, with a median of -$49.8 million in 2021.
• Annual changes were most pronounced in 2023 — Free Cash Flow plunged 8513.94% — and 2025, when it soared 145.83%.
• Legend Biotech's Free Cash Flow stood at -$156.3 million in 2021, then surged by 81.56% to -$28.8 million in 2022, then tumbled by 356.25% to -$131.5 million in 2023, then rose by 17.9% to -$107.9 million in 2024, then soared by 88.7% to -$12.2 million in 2025.
• The last three Free Cash Flow figures came in at -$12.2 million (Q4 2025), $33.8 million (Q3 2025), and -$3.8 million (Q2 2025), per Business Quant data.